The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
05/19/2009
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
RFA-AI-09-024
Opportunity Category:
Discretionary
Posted Date:
May 19, 2009
Creation Date:
May 19, 2009
Original Closing Date for Applications:
Nov 09, 2009
Current Closing Date for Applications:
Nov 09, 2009
Archive Date:
Dec 10, 2009
Funding Instrument Type:
Grant
Category of Funding Activity:
Health
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
$10,000,000
Award Ceiling:
$350,000
Award Floor:
CFDA Number(s):
93.855
--
Allergy, Immunology and Transplantation Research
93.856
--
Microbiology and Infectious Diseases Research
Cost Sharing or Matching Requirement:
No
Eligible Applicants
State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Agency Name
National Institutes of Health
Description
Purpose. The aim of this Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), is to stimulate the discovery of an effective prophylactic HIV-1 vaccine by soliciting Research Project Grant (R01) applications for hypothesis-driven basic research in HIV/AIDS, and general virology and immunology focused on that aim. The emphasis is on discovery, including the identification of new concepts and approaches that will inform the design of an optimal prophylactic HIV-1 vaccine, or the implementation of applicable concepts and/or approaches that have been employed successfully in the development of vaccines for other infections.
Mechanism of Support. This FOA will utilize the NIH Research Project R01 grant mechanism. This FOA will utilize the NIH Research Project R01 grant mechanism, and runs in parallel with FOAs of similar scope, including PA-06-519 Phased Innovation Awards (PIA) in AIDS Vaccine Research and PAR-06-285 HIVRAD that solicit applications under the R21/R33 and P01 mechanisms, respectively.
Funds Available and Anticipated Number of Awards. NIAID intends to commit approximately $10M in total costs in FY 2010 to fund 15-25 applications submitted in response to this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
